THE POSSIBILITY OF PROGNOSIS INCIDENCE BY MEANS OF DEGREES OF CANCER AGGRAVATED FAMILY HISTORY

Cover Page

Abstract


Background: Aim of the study was to estimate the possibility of prognosis incidence by means of degrees of cancer aggravated family history. Patients and methods: 1233 families (n =4689) from the Moscow Cancer Family Registry who answered 5-years later the first questionnaire were divided into 4 groups according to our classification of degrees of cancer aggravated family history: (1) not aggravated, (2) little aggravated, (3) aggravated, (4) syndromes (see detailed description in the text). The methods of genetic epidemiology, epidemiology, statistics were used. Results: Incidence in the first and second groups were near population expected cases, some higher in the aggravated group and sharp rise in women from the syndromes-associated families (the most syndromes predisposed to cancer of women reproductive system), relative risk was 10,76 for probands and 8,19 for the first relative women. There was no increase in frequency of new cases among men in syndrome-associated families. Conclusion: Analysis of degrees of cancer aggravated family history can be used for the incidence prognosis; one or two cancer cases among first degree relations don’t regard as a high oncogenetic risk factor; members of families with syndromes are obligatory cancer risk group.


A. P. Chudina

N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation

Author for correspondence.
Email: chudina35@mail.ru

Russian Federation

ведущий научный сотрудник группы профилактики канцерогенных воздействий отдела химического канцерогенеза НИИ канцерогенеза РОНЦ им. Н.Н. Блохина
Адрес: 117478, Москва, Каширское ш., д. 24, тел.: (499) 324-73-51

  1. Чудина А.П. Проспективное исследование семей, включенных в онкогенетический регистр. Вопр. онкол. 2004; 50 (5): 540–543.
  2. Vasen H.F., Mecklin J.P., Khan P.M., Lynch H.T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-NPCC). Dis. Colon Rectum. 1991; 34: 424–425.
  3. Vasen H.F., Watson P., Mecklin J.P., Lynch H.T. New clinical criteria for hereditary Nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999; 16 (6): 1453–1456.
  4. Двойрин В.В., Аксель Е.М., Трапезников Н.Н. Заболеваемость злокачественными новообразованиями и смертность от них населения стран СНГ в 1995 г. М.: ОНЦ им. Н.Н. Блохина. 1996. С. 14–19.
  5. Smith A., Moran A., Boyd M.C., Bulman M., Shenton A., Smith L., Iddenden R., Woodward E.R., Lalloo F., Maher E.R., Evans D.G.R. Phenocopies in BRCA 1 and BRCA 2 families: evidence for modifier genes and implications for screening. J Med Genet. 2007; 44: 10–15.
  6. Kurian A.W., Gong G.D., John E.M., Johnston D.A., Felberg A., West D.W., Miron A., Andrulis I.L., Hopper J.L., Knight J.A., Ozcelik H., Dite G.S., Apicella C., Southey M.C., Whittermore A.S. Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry. J. Clin. Oncol. 2011; 29 (34): 4505–4509.
  7. Lynch H.T., Lynch J.F., Lynch P.M., Attard T. Hereditary colorectal syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam. Cancer. 2008; 7 (1): 27–39.

Views

Abstract - 25

PDF (Russian) - 18

Cited-By


PlumX



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.